Immunoclin (Immunoclin) Interest Expense : $0.00 Mil (TTM As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Immunoclin's interest expense for the three months ended in Oct. 2014 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Oct. 2014 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Immunoclin's Operating Income for the three months ended in Oct. 2014 was $ -1.15 Mil. Immunoclin's Interest Expense for the three months ended in Oct. 2014 was $ 0.00 Mil. Immunoclin has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Immunoclin Interest Expense Historical Data

The historical data trend for Immunoclin's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Interest Expense Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Interest Expense

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Interest Expense	Get a 7-Day Free Trial									-	-	-	-	-

Immunoclin Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Oct. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Immunoclin (GREY:IMCL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Immunoclin's Interest Expense for the three months ended in Oct. 2014 was $0.00 Mil. Its Operating Income for the three months ended in Oct. 2014 was $-1.15 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Oct. 2014 was $0.00 Mil.

Immunoclin's Interest Coverage for the quarter that ended in Oct. 2014 is calculated as

Immunoclin had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines